Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin

Pediatric Infectious Disease Journal

Volumn 15, Issue 11, 1996, Pages 980-985

  Dagan, Ron ^a   Abramson, Oren ^a   Leibovitz, Eugene ^a   Lang, Ruth ^b   Goshen, Sivan ^b   Greenberg, David ^a   Yagupsky, Pablo ^a   Leiberman, Alberto ^a   Fliss, Dan M ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

antibiotic resistance; cephalosporins; Otitis media; Streptococcus pneumoniae

Indexed keywords

CEFACLOR; CEFUROXIME AXETIL;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFANT; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; CEFACLOR; CEFUROXIME; CEPHALOSPORINS; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 0029852496     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199611000-00010     Document Type: Article

References (37)

1. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11:S7-11.
2. Applebaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis 1992;15:77-83.
3. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am 1995;42:509-17.
4. Schreiber JR, Jacobs MR. Antibiotic-resistant pneumococci. Pediatr Clin North Am 1995;42:519-37.
5. Jackson MA, Shelton S, Nelson JD, McCracken GH Jr. Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis J 1984;3:129-32.
6. Spika JS, Facklam RR, Plikaytis BD, Oxtboy MJ, and the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
7. Block S, Hedrick J, Wright P, et al. Drug-resistant Streptococcus pneumoniae: Kentucky and Tennessee, 1993. MMWR 1994;43:23-5.
8. Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992;15:95-8.
9. Berche P, Bouchot I, Duval F, Gehanno P, Lenoir G. Incidences des pneumococcues de sensibilité abnormale à la pénicilline en France chez l'enfant présentant une otite moyenne aigué. In: Actualités des Streptococcus, January 27 to 28, 1994. Paris: Société Française de Microbiologie, 1994:26.
10. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995;39:271-2.
11. Barry B, Gehanno P, Blumen M, Boucot I. Clinical outcome of acute otitis media caused by pneumococci with decreased susceptibility to penicillin. Scand J Infect Dis 1994;26:446-52.
12. Dagan R, Yagupsky P, Goldbart A, Wasas A, Klugman K. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J 1994;13: 782-6.
13. Jacobs MR, Bajaksouzian S, Burch DJ, Applebaum PC. Activity of amoxicillin ± clavulanate against Streptococcus pneumoniae strains from patients with acute otitis media in Eastern Europe, Israel and the US [Abstract E-29]. Presented at the 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 18 to 20, 1995.
14. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-5.
15. Howie YM, Ploussard JH. The "in vivo" sensitivity: bacteriology of middle ear exudate. Pediatrics 1969;44:940-4.
16. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon." J Pediatr 1992; 120:72-7.
17. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med NY 1976;43:669-705.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Sixth Informed Supplement. NCCLS Document M100-S6, vol. 15, no. 14. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995.
19. Friedland IR, McCracken H Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
20. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333: 474-80.
21. Barnett ED, Bolduc GR, Pelton SI, Klein JO. Resistance to trimethoprim-sulfamethoxazole of Streptococcus pneumoniae in the nasopharynx predicts clinical outcome in children with acute otitis media. Pediatr Res 1993;33:162A.
22. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995;14:885-90.
23. Cohen R, Levy C, de La Rocque F, et al. Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae increases the risk of antibiotic treatment failure in acute otitis media [Abstract C-6]. Presented at the 35th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 18 to 20, 1995.
24. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995;127: 533-7.
25. Linares J, Alonso T, Pérez JL, et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother 1992;30:279-88.
26. Nelson CT, Mason ED Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
27. Spangler SK, Jacobs MR, Applebaum PC. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY 49605 (SUN/SY 5555), a new oral penem compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime and cefdinir. Antimicrob Agents Chemother 1994;38:2902-4.
28. Spangler SK, Jacobs MR, Pankuch GA, Applebaum PC. Susceptibility of 170 penicillin-susceptible and -resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, RO 23-9424 and RP 67829. J Antimicrob Chemother 1993;31:273-80.
29. Thornberry CS, Brown SD, Yee YC, Bouchillon SK, Marier JK, Rich T. Increasing penicillin resistance in Streptococcus pneumoniae in the US: effect on susceptibility to oral cephalosporins. Infect Med 1993;Suppl:15-23.
30. Pankuch GA, Visalli MA, Jacobs MR, Applebaum PC. Activity of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1995;39:1499-504.
31. Barry B, Muffat-Joly M, Gehanno P, Pocidalo JJ. Effect of increased dosage of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1993;37: 1599-603.
32. Knudsen JD, Frimodt-Moller N, Espersen F. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother 1995;39:1253-8.
33. Frimodt-Młler N, Bentron MN, Thomsen VF. Experimental infections with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis 1986;154:511-7.
34. McLinn SE. Cefaclor in treatment of otitis media and pharyngitis in children. Am J Dis Child 1980;134:560-3.
35. Marchant CD, Shurin PA, Turcyzk VA, et al. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media. J Pediatr 1984;105:633-8.
36. Marchant CD, Shurin PA, Johnson CE, et al. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr 1986; 109:891-6.
37. Howie VM. Eradication of bacterial pathogens from middle ear infection. Clin Infect Dis 1992;14(Suppl 2):209-10.